Récher, C., Pautas, C., Bertoli, S., Dumas, P., Raffoux, E., Hospital, M., Prince-Eladnani, R., Heiblig, M., Carré, M., Chantepie, S., Peterlin, P., Hernanz, M. P. G., Lambert, J., Orvain, C., Guieze, R., Turlure, P., Simand, C., Lemasle, E., Himberlin, C., Bonmati, C., Malfuson, J. V., Lebon, D., Cluzeau, T., Tavernier, E., Micol, J., Celli-Lebras, K., Mineur, A., Gardin, C., Ifrah, N., Vey, N., Latour, R. P. D., Huynh, A., Leguay, T., Luquet, I., Penther, D., Duployez, N., Delabesse, Ã., Preudhomme, C., Dombret, H., Hamel, J., Pigneux, A., Mathilde, H. (2025). Induction chemotherapy with a single anthracycline-containing cycle in younger adults with newly diagnosed AML – the french backbone intergroup (BIG)-1 study on behalf of the filo, ALFA, and SFGM-TC study groups. Blood. https://doi.org/10.1182/blood-2025-43